GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $203,000 | -2.4% | 4,672 | -2.2% | 0.07% | -14.9% |
| Q1 2022 | $208,000 | -11.5% | 4,775 | -10.6% | 0.09% | -6.5% |
| Q4 2021 | $235,000 | +6.3% | 5,340 | -7.5% | 0.09% | -2.1% |
| Q3 2021 | $221,000 | -3.9% | 5,772 | +0.1% | 0.10% | -24.6% |
| Q2 2021 | $230,000 | +12.2% | 5,766 | +0.6% | 0.13% | +5.9% |
| Q1 2021 | $205,000 | -21.8% | 5,734 | -19.4% | 0.12% | -28.3% |
| Q4 2020 | $262,000 | -47.6% | 7,110 | -46.5% | 0.17% | -48.3% |
| Q3 2020 | $500,000 | -13.3% | 13,288 | -6.1% | 0.32% | -32.7% |
| Q2 2020 | $577,000 | -7.2% | 14,157 | -13.7% | 0.48% | -21.5% |
| Q1 2020 | $622,000 | -26.8% | 16,403 | -9.4% | 0.61% | +3.4% |
| Q4 2019 | $850,000 | +0.2% | 18,097 | -8.9% | 0.59% | -16.0% |
| Q3 2019 | $848,000 | +3.8% | 19,859 | -1.5% | 0.70% | -2.1% |
| Q2 2019 | $817,000 | -4.0% | 20,161 | -1.0% | 0.72% | -4.5% |
| Q1 2019 | $851,000 | – | 20,374 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |